1. Home
  2. HZO vs ESPR Comparison

HZO vs ESPR Comparison

Compare HZO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HZO
  • ESPR
  • Stock Information
  • Founded
  • HZO 1998
  • ESPR 2008
  • Country
  • HZO United States
  • ESPR United States
  • Employees
  • HZO N/A
  • ESPR N/A
  • Industry
  • HZO Auto & Home Supply Stores
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • HZO Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • HZO Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • HZO 499.9M
  • ESPR 445.6M
  • IPO Year
  • HZO 1998
  • ESPR 2013
  • Fundamental
  • Price
  • HZO $26.17
  • ESPR $2.78
  • Analyst Decision
  • HZO Strong Buy
  • ESPR Buy
  • Analyst Count
  • HZO 4
  • ESPR 6
  • Target Price
  • HZO $33.25
  • ESPR $6.50
  • AVG Volume (30 Days)
  • HZO 270.3K
  • ESPR 6.0M
  • Earning Date
  • HZO 10-30-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • HZO N/A
  • ESPR N/A
  • EPS Growth
  • HZO N/A
  • ESPR N/A
  • EPS
  • HZO N/A
  • ESPR N/A
  • Revenue
  • HZO $2,320,257,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • HZO N/A
  • ESPR $10.59
  • Revenue Next Year
  • HZO $3.85
  • ESPR N/A
  • P/E Ratio
  • HZO N/A
  • ESPR N/A
  • Revenue Growth
  • HZO N/A
  • ESPR N/A
  • 52 Week Low
  • HZO $16.85
  • ESPR $0.69
  • 52 Week High
  • HZO $37.86
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • HZO 52.06
  • ESPR 74.91
  • Support Level
  • HZO $24.71
  • ESPR $2.37
  • Resistance Level
  • HZO $26.84
  • ESPR $2.73
  • Average True Range (ATR)
  • HZO 1.01
  • ESPR 0.17
  • MACD
  • HZO -0.11
  • ESPR 0.02
  • Stochastic Oscillator
  • HZO 43.71
  • ESPR 85.71

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: